| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| E-Selectin | 30 | 2022 | 576 | 6.250 |
Why?
|
| Fucose | 13 | 2022 | 122 | 2.720 |
Why?
|
| Mesenchymal Stem Cells | 14 | 2024 | 1642 | 2.280 |
Why?
|
| Fucosyltransferases | 12 | 2022 | 117 | 2.270 |
Why?
|
| Cell Movement | 28 | 2019 | 5202 | 2.110 |
Why?
|
| L-Selectin | 16 | 2017 | 209 | 2.070 |
Why?
|
| Glycosyltransferases | 7 | 2018 | 117 | 1.990 |
Why?
|
| Glycomics | 5 | 2019 | 113 | 1.810 |
Why?
|
| Polysaccharides | 13 | 2021 | 1014 | 1.660 |
Why?
|
| Ligands | 31 | 2022 | 3271 | 1.620 |
Why?
|
| Hematopoietic Stem Cells | 23 | 2017 | 3396 | 1.410 |
Why?
|
| Cell Adhesion | 27 | 2022 | 3089 | 1.310 |
Why?
|
| Selectins | 5 | 2016 | 101 | 1.050 |
Why?
|
| Lymphocytes | 16 | 2008 | 2610 | 1.030 |
Why?
|
| T-Lymphocytes | 15 | 2022 | 10191 | 0.860 |
Why?
|
| Glycoproteins | 7 | 2023 | 2207 | 0.820 |
Why?
|
| Endothelial Cells | 6 | 2022 | 3543 | 0.820 |
Why?
|
| Bone Marrow Cells | 8 | 2017 | 2416 | 0.770 |
Why?
|
| Membrane Glycoproteins | 13 | 2018 | 3701 | 0.760 |
Why?
|
| Glycopeptides | 1 | 2022 | 220 | 0.750 |
Why?
|
| Glycosylation | 11 | 2024 | 1098 | 0.750 |
Why?
|
| Tongue Neoplasms | 1 | 2023 | 183 | 0.750 |
Why?
|
| Myeloid Cells | 3 | 2014 | 823 | 0.740 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 7 | 2014 | 629 | 0.720 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2023 | 1186 | 0.670 |
Why?
|
| Heparitin Sulfate | 2 | 2018 | 223 | 0.630 |
Why?
|
| Blotting, Western | 7 | 2015 | 5034 | 0.620 |
Why?
|
| Neuraminidase | 5 | 2017 | 199 | 0.610 |
Why?
|
| Oligosaccharides | 2 | 2018 | 406 | 0.610 |
Why?
|
| Chemotaxis, Leukocyte | 6 | 2020 | 664 | 0.590 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2018 | 100 | 0.590 |
Why?
|
| Cell Communication | 5 | 2021 | 1657 | 0.560 |
Why?
|
| Leukocytes | 6 | 2020 | 2029 | 0.550 |
Why?
|
| Protein Engineering | 4 | 2019 | 550 | 0.550 |
Why?
|
| P-Selectin | 7 | 2009 | 597 | 0.550 |
Why?
|
| Immunologic Surveillance | 1 | 2017 | 92 | 0.540 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2018 | 499 | 0.540 |
Why?
|
| Biotechnology | 1 | 2018 | 282 | 0.540 |
Why?
|
| Bone Marrow Transplantation | 12 | 2004 | 2693 | 0.530 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2018 | 1842 | 0.510 |
Why?
|
| Chemokines | 5 | 2018 | 960 | 0.500 |
Why?
|
| Head and Neck Neoplasms | 3 | 2023 | 2891 | 0.500 |
Why?
|
| Graft vs Host Disease | 13 | 2020 | 3030 | 0.490 |
Why?
|
| Skin | 8 | 2004 | 4482 | 0.480 |
Why?
|
| Models, Immunological | 1 | 2017 | 512 | 0.480 |
Why?
|
| Acetylglucosamine | 3 | 2009 | 189 | 0.460 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2014 | 50 | 0.450 |
Why?
|
| Receptors, Lymphocyte Homing | 5 | 2005 | 141 | 0.450 |
Why?
|
| Mechanical Phenomena | 1 | 2015 | 141 | 0.440 |
Why?
|
| Cell Adhesion Molecules | 6 | 2006 | 1600 | 0.440 |
Why?
|
| Isoenzymes | 1 | 2018 | 1688 | 0.430 |
Why?
|
| Endothelium, Vascular | 7 | 2009 | 4432 | 0.430 |
Why?
|
| Chemokine CXCL12 | 4 | 2009 | 454 | 0.430 |
Why?
|
| Hematopoiesis | 6 | 2022 | 2049 | 0.430 |
Why?
|
| Leukocytosis | 1 | 2014 | 251 | 0.410 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2020 | 1805 | 0.410 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2019 | 1469 | 0.400 |
Why?
|
| Endothelium | 7 | 2020 | 765 | 0.400 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 85 | 0.400 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2014 | 436 | 0.400 |
Why?
|
| Glycoconjugates | 3 | 2022 | 88 | 0.400 |
Why?
|
| Bone and Bones | 2 | 2016 | 2568 | 0.400 |
Why?
|
| Transplantation, Heterologous | 11 | 2016 | 2385 | 0.390 |
Why?
|
| Cell Line | 14 | 2020 | 15599 | 0.390 |
Why?
|
| Chemokine CCL5 | 2 | 2009 | 215 | 0.390 |
Why?
|
| Animals | 68 | 2022 | 168388 | 0.390 |
Why?
|
| Antigens, CD34 | 3 | 2011 | 658 | 0.370 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2020 | 3075 | 0.370 |
Why?
|
| Neoplastic Stem Cells | 4 | 2021 | 1348 | 0.370 |
Why?
|
| Peroxidase | 1 | 2014 | 610 | 0.370 |
Why?
|
| Monocytes | 2 | 2018 | 2573 | 0.350 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 21 | 2022 | 5670 | 0.340 |
Why?
|
| CHO Cells | 6 | 2015 | 1389 | 0.340 |
Why?
|
| Career Choice | 1 | 2016 | 756 | 0.340 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2015 | 822 | 0.340 |
Why?
|
| Dendritic Cells | 2 | 2018 | 2746 | 0.330 |
Why?
|
| Cells, Cultured | 13 | 2020 | 18962 | 0.330 |
Why?
|
| Cricetinae | 6 | 2015 | 2427 | 0.320 |
Why?
|
| Humans | 118 | 2024 | 761326 | 0.310 |
Why?
|
| Graft vs Tumor Effect | 2 | 2006 | 68 | 0.310 |
Why?
|
| Neoplasm Proteins | 3 | 2011 | 3611 | 0.310 |
Why?
|
| Bioethics | 1 | 2010 | 117 | 0.310 |
Why?
|
| Chemotaxis | 2 | 2009 | 599 | 0.310 |
Why?
|
| Protein Binding | 7 | 2019 | 9351 | 0.310 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 11900 | 0.300 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 888 | 0.300 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 900 | 0.290 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2008 | 95 | 0.290 |
Why?
|
| Hyaluronic Acid | 2 | 2018 | 482 | 0.290 |
Why?
|
| Cell Differentiation | 9 | 2021 | 11531 | 0.290 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 4022 | 0.290 |
Why?
|
| Colonic Neoplasms | 4 | 2008 | 2534 | 0.280 |
Why?
|
| Fetal Blood | 2 | 2022 | 1347 | 0.280 |
Why?
|
| Leukocyte Rolling | 2 | 2005 | 69 | 0.270 |
Why?
|
| Mice | 32 | 2022 | 81474 | 0.270 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 200 | 0.270 |
Why?
|
| Integrin alpha4beta1 | 3 | 2011 | 119 | 0.260 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 2 | 2004 | 263 | 0.260 |
Why?
|
| Coculture Techniques | 5 | 2018 | 1341 | 0.240 |
Why?
|
| Lymph Nodes | 9 | 2008 | 3469 | 0.240 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1508 | 0.240 |
Why?
|
| Mice, Inbred NOD | 3 | 2019 | 1825 | 0.240 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2011 | 946 | 0.240 |
Why?
|
| Transplantation Immunology | 2 | 2006 | 532 | 0.230 |
Why?
|
| Neoplasms | 6 | 2021 | 22158 | 0.230 |
Why?
|
| Immunophenotyping | 4 | 2018 | 1870 | 0.230 |
Why?
|
| Stress, Physiological | 2 | 2009 | 1403 | 0.230 |
Why?
|
| Stress, Mechanical | 4 | 2015 | 1674 | 0.220 |
Why?
|
| Dermatitis, Contact | 1 | 2003 | 133 | 0.210 |
Why?
|
| N-Acetylneuraminic Acid | 3 | 2016 | 174 | 0.210 |
Why?
|
| Bone Marrow | 3 | 2016 | 2909 | 0.210 |
Why?
|
| Orosomucoid | 1 | 2022 | 47 | 0.210 |
Why?
|
| Stromal Cells | 2 | 2008 | 1330 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2011 | 8527 | 0.210 |
Why?
|
| Transplantation Conditioning | 10 | 2005 | 1590 | 0.210 |
Why?
|
| Methylprednisolone | 2 | 1995 | 384 | 0.210 |
Why?
|
| Biological Assay | 1 | 2006 | 626 | 0.210 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1262 | 0.200 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 16966 | 0.200 |
Why?
|
| Transplantation, Homologous | 14 | 2020 | 4810 | 0.200 |
Why?
|
| Immunotherapy | 2 | 2018 | 4649 | 0.200 |
Why?
|
| Neutrophils | 2 | 2016 | 3765 | 0.200 |
Why?
|
| Ions | 1 | 2022 | 256 | 0.200 |
Why?
|
| Mucins | 2 | 2023 | 568 | 0.200 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2021 | 1974 | 0.190 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2022 | 167 | 0.190 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 3 | 2006 | 377 | 0.190 |
Why?
|
| Research | 1 | 2010 | 1977 | 0.190 |
Why?
|
| Cryopreservation | 3 | 2024 | 728 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 3441 | 0.180 |
Why?
|
| Flow Cytometry | 7 | 2018 | 5866 | 0.180 |
Why?
|
| Cricetulus | 2 | 2015 | 815 | 0.170 |
Why?
|
| Immunomodulation | 1 | 2024 | 547 | 0.170 |
Why?
|
| GATA3 Transcription Factor | 1 | 2020 | 152 | 0.170 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2001 | 130 | 0.170 |
Why?
|
| Galectins | 1 | 2022 | 295 | 0.170 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 5 | 2004 | 225 | 0.170 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2020 | 152 | 0.170 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 5 | 2005 | 899 | 0.160 |
Why?
|
| Polydeoxyribonucleotides | 1 | 2020 | 136 | 0.160 |
Why?
|
| Drug Repositioning | 1 | 2021 | 233 | 0.160 |
Why?
|
| Fibronectins | 3 | 2017 | 723 | 0.160 |
Why?
|
| Leukemia | 2 | 2022 | 1523 | 0.160 |
Why?
|
| Thrombocytopenia | 4 | 2022 | 1179 | 0.160 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2011 | 691 | 0.160 |
Why?
|
| Transplantation Chimera | 5 | 2005 | 594 | 0.160 |
Why?
|
| Testis | 1 | 2022 | 794 | 0.160 |
Why?
|
| Immune Tolerance | 4 | 2020 | 2300 | 0.150 |
Why?
|
| Amino Sugars | 1 | 2018 | 39 | 0.150 |
Why?
|
| Cell Survival | 4 | 2018 | 5792 | 0.150 |
Why?
|
| Shear Strength | 2 | 2009 | 160 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 3793 | 0.150 |
Why?
|
| Cation Transport Proteins | 1 | 2020 | 326 | 0.150 |
Why?
|
| Neoplasm Metastasis | 4 | 2019 | 4908 | 0.150 |
Why?
|
| Exanthema | 1 | 2002 | 504 | 0.150 |
Why?
|
| Prostaglandins F | 1 | 2017 | 80 | 0.150 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2020 | 1351 | 0.140 |
Why?
|
| Stem Cells | 2 | 2010 | 3521 | 0.140 |
Why?
|
| Manganese | 1 | 2020 | 395 | 0.140 |
Why?
|
| Major Histocompatibility Complex | 4 | 1985 | 927 | 0.140 |
Why?
|
| Click Chemistry | 1 | 2018 | 95 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2022 | 1135 | 0.140 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 768 | 0.140 |
Why?
|
| Thoracic Duct | 2 | 1995 | 64 | 0.140 |
Why?
|
| Papio | 8 | 2002 | 669 | 0.140 |
Why?
|
| Mice, SCID | 2 | 2019 | 2625 | 0.140 |
Why?
|
| Acute Disease | 6 | 2020 | 7238 | 0.140 |
Why?
|
| Antigens, Surface | 3 | 2001 | 1609 | 0.140 |
Why?
|
| Transfection | 4 | 2016 | 5776 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1170 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2005 | 1745 | 0.130 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2016 | 101 | 0.130 |
Why?
|
| Cell Membrane | 2 | 2016 | 3687 | 0.130 |
Why?
|
| Education, Professional | 1 | 2016 | 52 | 0.130 |
Why?
|
| Intracellular Space | 1 | 2016 | 197 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 702 | 0.120 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2015 | 122 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2014 | 4120 | 0.120 |
Why?
|
| Thrombosis | 4 | 2001 | 2942 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 687 | 0.120 |
Why?
|
| Receptors, CXCR4 | 2 | 2011 | 727 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2021 | 1139 | 0.120 |
Why?
|
| Hematologic Neoplasms | 7 | 2005 | 1896 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2016 | 563 | 0.120 |
Why?
|
| Immunosuppressive Agents | 4 | 2006 | 4173 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2017 | 2549 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 6 | 2016 | 22154 | 0.120 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14409 | 0.110 |
Why?
|
| Tumor Escape | 1 | 2017 | 370 | 0.110 |
Why?
|
| Biocatalysis | 1 | 2014 | 170 | 0.110 |
Why?
|
| Immune System Diseases | 1 | 2016 | 257 | 0.110 |
Why?
|
| Cell Lineage | 2 | 2020 | 2556 | 0.110 |
Why?
|
| Immunologic Memory | 1 | 2020 | 1359 | 0.110 |
Why?
|
| Lymphocyte Activation | 2 | 2020 | 5491 | 0.110 |
Why?
|
| Kinetics | 5 | 2016 | 6374 | 0.110 |
Why?
|
| Autoimmunity | 1 | 2021 | 1355 | 0.110 |
Why?
|
| Vaccines | 1 | 2021 | 837 | 0.100 |
Why?
|
| Antigens, CD1 | 2 | 2008 | 439 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2018 | 12787 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 1993 | 2820 | 0.100 |
Why?
|
| Antigens | 1 | 2018 | 1446 | 0.100 |
Why?
|
| Epitopes | 3 | 2008 | 2504 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2017 | 1967 | 0.100 |
Why?
|
| Refrigeration | 1 | 2011 | 27 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2018 | 4355 | 0.100 |
Why?
|
| Structure-Activity Relationship | 2 | 2011 | 3076 | 0.100 |
Why?
|
| Antigens, Neoplasm | 4 | 2005 | 1994 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2014 | 2188 | 0.100 |
Why?
|
| Chemokines, CXC | 2 | 2006 | 422 | 0.100 |
Why?
|
| Skull | 1 | 2016 | 818 | 0.100 |
Why?
|
| Metalloproteases | 1 | 2011 | 61 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1549 | 0.100 |
Why?
|
| Benzylamines | 2 | 2009 | 247 | 0.100 |
Why?
|
| Lymphopenia | 1 | 1993 | 280 | 0.100 |
Why?
|
| Heterocyclic Compounds | 2 | 2009 | 246 | 0.100 |
Why?
|
| Peptides | 2 | 2022 | 4342 | 0.090 |
Why?
|
| Bioengineering | 1 | 2012 | 99 | 0.090 |
Why?
|
| Body Size | 1 | 2014 | 463 | 0.090 |
Why?
|
| Biomedical Research | 2 | 2017 | 3429 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2193 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2468 | 0.090 |
Why?
|
| Blood Platelets | 2 | 2011 | 2481 | 0.090 |
Why?
|
| Psoriasis | 2 | 1989 | 939 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1669 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2018 | 1085 | 0.090 |
Why?
|
| HL-60 Cells | 2 | 2001 | 363 | 0.090 |
Why?
|
| Lymphocyte Depletion | 4 | 2006 | 602 | 0.090 |
Why?
|
| Organ Transplantation | 2 | 2016 | 1157 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1726 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 221 | 0.090 |
Why?
|
| Complement C4 | 3 | 1985 | 244 | 0.090 |
Why?
|
| Colitis | 1 | 2018 | 1231 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 731 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2016 | 1567 | 0.080 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 242 | 0.080 |
Why?
|
| Mutation | 1 | 2014 | 30044 | 0.080 |
Why?
|
| Microscopy | 1 | 2015 | 902 | 0.080 |
Why?
|
| Nerve Regeneration | 1 | 2015 | 795 | 0.080 |
Why?
|
| Interleukin-2 | 3 | 2003 | 1891 | 0.080 |
Why?
|
| Sialic Acids | 2 | 2000 | 123 | 0.080 |
Why?
|
| Chondroitin Sulfates | 1 | 2009 | 174 | 0.080 |
Why?
|
| Endothelium, Lymphatic | 1 | 1988 | 63 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 8 | 2008 | 9180 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 800 | 0.080 |
Why?
|
| Transplantation, Autologous | 6 | 2004 | 2115 | 0.080 |
Why?
|
| Complement Factor B | 2 | 1985 | 72 | 0.080 |
Why?
|
| Peyer's Patches | 1 | 1988 | 119 | 0.080 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 307 | 0.080 |
Why?
|
| Lymph | 1 | 2008 | 77 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2016 | 2770 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6332 | 0.070 |
Why?
|
| Rheology | 1 | 2009 | 348 | 0.070 |
Why?
|
| Histocompatibility | 3 | 2004 | 317 | 0.070 |
Why?
|
| Blood Coagulation Disorders | 2 | 2000 | 350 | 0.070 |
Why?
|
| Cell Transplantation | 2 | 2018 | 472 | 0.070 |
Why?
|
| Solubility | 1 | 2008 | 1091 | 0.070 |
Why?
|
| Swine | 9 | 2002 | 5915 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2527 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2008 | 1374 | 0.070 |
Why?
|
| Swine, Miniature | 4 | 2002 | 961 | 0.070 |
Why?
|
| Cytokines | 7 | 2022 | 7390 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2015 | 1375 | 0.070 |
Why?
|
| Sialyltransferases | 1 | 2006 | 83 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1995 | 1875 | 0.070 |
Why?
|
| Receptors, Chemokine | 2 | 2008 | 653 | 0.070 |
Why?
|
| Nitroimidazoles | 1 | 2007 | 117 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2014 | 4576 | 0.060 |
Why?
|
| Lymphocyte Transfusion | 2 | 2005 | 232 | 0.060 |
Why?
|
| Leukemia, Myeloid | 2 | 2000 | 694 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6128 | 0.060 |
Why?
|
| Chemokines, CC | 1 | 2006 | 283 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2002 | 4000 | 0.060 |
Why?
|
| Microscopy, Video | 1 | 2006 | 242 | 0.060 |
Why?
|
| Signal Transduction | 5 | 2019 | 23427 | 0.060 |
Why?
|
| Cell Proliferation | 5 | 2021 | 10431 | 0.060 |
Why?
|
| CD40 Ligand | 3 | 2002 | 526 | 0.060 |
Why?
|
| Perfusion | 2 | 2007 | 1374 | 0.060 |
Why?
|
| Triazines | 1 | 2007 | 311 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3310 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 698 | 0.060 |
Why?
|
| Pneumonia | 1 | 2016 | 2140 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 3428 | 0.060 |
Why?
|
| Multiple Myeloma | 4 | 2008 | 5146 | 0.060 |
Why?
|
| Enzyme Precursors | 1 | 1984 | 174 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3792 | 0.060 |
Why?
|
| Stem Cell Transplantation | 2 | 2010 | 1598 | 0.060 |
Why?
|
| Stem Cell Niche | 2 | 2019 | 345 | 0.060 |
Why?
|
| Carbohydrate Sequence | 2 | 2002 | 411 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2005 | 1698 | 0.060 |
Why?
|
| Mycophenolic Acid | 2 | 2002 | 348 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2004 | 397 | 0.050 |
Why?
|
| Swainsonine | 1 | 2002 | 9 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2024 | 1809 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3108 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2008 | 1037 | 0.050 |
Why?
|
| von Willebrand Factor | 2 | 2011 | 673 | 0.050 |
Why?
|
| Tunicamycin | 1 | 2002 | 108 | 0.050 |
Why?
|
| Integrin alpha5beta1 | 1 | 2002 | 37 | 0.050 |
Why?
|
| Leydig Cells | 1 | 2022 | 55 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2006 | 1250 | 0.050 |
Why?
|
| Hemorheology | 1 | 2002 | 144 | 0.050 |
Why?
|
| Lymphopoiesis | 1 | 2002 | 133 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2020 | 6937 | 0.050 |
Why?
|
| Kidney Transplantation | 3 | 2002 | 4236 | 0.050 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2001 | 126 | 0.050 |
Why?
|
| Leukapheresis | 4 | 2002 | 134 | 0.050 |
Why?
|
| Bromelains | 1 | 2000 | 8 | 0.050 |
Why?
|
| Killer Cells, Natural | 2 | 2008 | 2203 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 815 | 0.050 |
Why?
|
| Anthelmintics | 1 | 2021 | 83 | 0.050 |
Why?
|
| rho-Associated Kinases | 1 | 2022 | 281 | 0.050 |
Why?
|
| Genes | 2 | 1984 | 1844 | 0.050 |
Why?
|
| Male | 23 | 2022 | 360621 | 0.050 |
Why?
|
| Carbohydrate Conformation | 1 | 2000 | 206 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 1993 | 4936 | 0.040 |
Why?
|
| Glycoside Hydrolases | 1 | 2000 | 135 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2008 | 1378 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3666 | 0.040 |
Why?
|
| Biopsy | 2 | 2020 | 6768 | 0.040 |
Why?
|
| Pneumocystis | 1 | 1999 | 55 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 9030 | 0.040 |
Why?
|
| Survival Analysis | 5 | 2004 | 10075 | 0.040 |
Why?
|
| Naphthoquinones | 1 | 1999 | 58 | 0.040 |
Why?
|
| Adult | 18 | 2021 | 221122 | 0.040 |
Why?
|
| K562 Cells | 1 | 2001 | 642 | 0.040 |
Why?
|
| Anti-HIV Agents | 2 | 2009 | 4524 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 431 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 18234 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 2001 | 365 | 0.040 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2008 | 1073 | 0.040 |
Why?
|
| Medically Underserved Area | 1 | 2021 | 256 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 2 | 2002 | 2471 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2000 | 393 | 0.040 |
Why?
|
| Thymus Gland | 3 | 2003 | 1241 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2019 | 191 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2001 | 584 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2004 | 6815 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13635 | 0.040 |
Why?
|
| Consumer Health Information | 1 | 2021 | 215 | 0.040 |
Why?
|
| Megakaryocytes | 1 | 2022 | 566 | 0.040 |
Why?
|
| Sialoglycoproteins | 1 | 2019 | 315 | 0.040 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1999 | 242 | 0.040 |
Why?
|
| Graft Survival | 3 | 2004 | 3818 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2003 | 1254 | 0.040 |
Why?
|
| Phylogeny | 1 | 1985 | 2809 | 0.040 |
Why?
|
| Middle Aged | 20 | 2021 | 220774 | 0.040 |
Why?
|
| Chlorates | 1 | 1997 | 12 | 0.040 |
Why?
|
| Lung | 2 | 2016 | 9994 | 0.040 |
Why?
|
| Models, Animal | 2 | 2001 | 2112 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1999 | 431 | 0.040 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 1999 | 220 | 0.040 |
Why?
|
| Leukocyte Transfusion | 3 | 2003 | 56 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2008 | 4167 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 17640 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10764 | 0.040 |
Why?
|
| Graft Rejection | 4 | 2005 | 4446 | 0.040 |
Why?
|
| Sialomucins | 1 | 1997 | 18 | 0.040 |
Why?
|
| Female | 23 | 2021 | 392485 | 0.040 |
Why?
|
| Steroids | 1 | 2002 | 928 | 0.040 |
Why?
|
| Salvage Therapy | 2 | 2001 | 1264 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 2018 | 302 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 1984 | 2114 | 0.040 |
Why?
|
| Pacemaker, Artificial | 2 | 1993 | 808 | 0.030 |
Why?
|
| Platelet Activation | 1 | 2000 | 645 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 1985 | 4286 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 1486 | 0.030 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2016 | 57 | 0.030 |
Why?
|
| Microcirculation | 1 | 2001 | 1269 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2001 | 1058 | 0.030 |
Why?
|
| DNA | 3 | 1985 | 7216 | 0.030 |
Why?
|
| Sulfates | 1 | 1997 | 380 | 0.030 |
Why?
|
| Cloning, Molecular | 4 | 1985 | 4175 | 0.030 |
Why?
|
| Community Health Services | 1 | 2021 | 656 | 0.030 |
Why?
|
| ADAM Proteins | 2 | 2011 | 237 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2015 | 12122 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 868 | 0.030 |
Why?
|
| Whole-Body Irradiation | 3 | 2000 | 433 | 0.030 |
Why?
|
| Peritoneum | 1 | 2016 | 225 | 0.030 |
Why?
|
| Interleukin-3 | 3 | 2002 | 425 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 1968 | 0.030 |
Why?
|
| Base Sequence | 4 | 2008 | 12449 | 0.030 |
Why?
|
| Oxygen | 1 | 2007 | 4227 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2000 | 11735 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1997 | 1060 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 1999 | 752 | 0.030 |
Why?
|
| Antigens, CD1d | 2 | 2008 | 228 | 0.030 |
Why?
|
| Cyclophosphamide | 4 | 2003 | 2218 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4567 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2000 | 1154 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 415 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 21009 | 0.030 |
Why?
|
| Drug Approval | 1 | 2021 | 814 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 736 | 0.030 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 1996 | 212 | 0.030 |
Why?
|
| Treatment Outcome | 9 | 2018 | 64645 | 0.030 |
Why?
|
| Leptin | 1 | 2022 | 1595 | 0.030 |
Why?
|
| Skin Diseases | 1 | 2002 | 1092 | 0.030 |
Why?
|
| Rats | 3 | 1997 | 23729 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1545 | 0.030 |
Why?
|
| Lymphoma | 1 | 2002 | 1901 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 27103 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1753 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2000 | 3969 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2021 | 1403 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1665 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 1995 | 778 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 1125 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 59196 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 2859 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1997 | 809 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2001 | 2082 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1984 | 1759 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1886 | 0.020 |
Why?
|
| HLA Antigens | 3 | 2003 | 1371 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2011 | 144 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 6309 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2020 | 2570 | 0.020 |
Why?
|
| Testosterone | 1 | 2022 | 2472 | 0.020 |
Why?
|
| Blood Preservation | 1 | 2011 | 168 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3590 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2001 | 516 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2020 | 2331 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 1995 | 13446 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3588 | 0.020 |
Why?
|
| Stem Cell Factor | 2 | 2000 | 195 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2001 | 411 | 0.020 |
Why?
|
| Hymecromone | 1 | 2009 | 9 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2021 | 1955 | 0.020 |
Why?
|
| Macrophages | 1 | 1984 | 5768 | 0.020 |
Why?
|
| Combined Modality Therapy | 5 | 2000 | 8526 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 8997 | 0.020 |
Why?
|
| Histocompatibility Testing | 2 | 2002 | 719 | 0.020 |
Why?
|
| Splenectomy | 2 | 2000 | 391 | 0.020 |
Why?
|
| Respiratory Muscles | 1 | 2009 | 142 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 3082 | 0.020 |
Why?
|
| Macaca fascicularis | 2 | 2000 | 903 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3873 | 0.020 |
Why?
|
| United States | 2 | 2021 | 72317 | 0.020 |
Why?
|
| Registries | 1 | 2004 | 8223 | 0.020 |
Why?
|
| Integrins | 1 | 2012 | 834 | 0.020 |
Why?
|
| Dermatitis | 1 | 1989 | 201 | 0.020 |
Why?
|
| Cyclosporine | 2 | 2000 | 778 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11070 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1984 | 555 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 10203 | 0.020 |
Why?
|
| Hematopoietic System | 1 | 2007 | 110 | 0.020 |
Why?
|
| Time Factors | 4 | 2002 | 39974 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 1988 | 445 | 0.020 |
Why?
|
| Remission Induction | 2 | 2005 | 2395 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2000 | 3234 | 0.020 |
Why?
|
| Epidermis | 1 | 1989 | 528 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 1405 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22124 | 0.020 |
Why?
|
| Complement C2 | 1 | 1985 | 70 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3592 | 0.020 |
Why?
|
| Antibody Formation | 2 | 2000 | 1397 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1861 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2488 | 0.020 |
Why?
|
| Aged | 8 | 2021 | 169179 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1992 | 1496 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2453 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6210 | 0.020 |
Why?
|
| Collodion | 1 | 1984 | 34 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1984 | 217 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1993 | 1555 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 892 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1989 | 1079 | 0.010 |
Why?
|
| Child | 2 | 2021 | 80156 | 0.010 |
Why?
|
| Haplotypes | 2 | 2002 | 2774 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8166 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 1993 | 1304 | 0.010 |
Why?
|
| Autoradiography | 1 | 1984 | 730 | 0.010 |
Why?
|
| Protozoan Infections | 1 | 2003 | 38 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1984 | 358 | 0.010 |
Why?
|
| Defibrillators, Implantable | 1 | 1993 | 1490 | 0.010 |
Why?
|
| Trachea | 1 | 2009 | 1089 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 7597 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 3613 | 0.010 |
Why?
|
| Cell Separation | 1 | 2008 | 1722 | 0.010 |
Why?
|
| Trisaccharides | 1 | 2002 | 50 | 0.010 |
Why?
|
| Reference Values | 1 | 1989 | 4921 | 0.010 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2002 | 98 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1988 | 1412 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2001 | 84 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2007 | 858 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2002 | 352 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2002 | 311 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1984 | 552 | 0.010 |
Why?
|
| Aspergillosis | 1 | 2003 | 243 | 0.010 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2003 | 237 | 0.010 |
Why?
|
| Platelet Count | 1 | 2004 | 781 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 2000 | 41 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 2001 | 248 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 1975 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 2000 | 77 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8635 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15835 | 0.010 |
Why?
|
| Phenotype | 3 | 2000 | 16603 | 0.010 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2000 | 57 | 0.010 |
Why?
|
| Models, Biological | 1 | 2016 | 9468 | 0.010 |
Why?
|
| Atovaquone | 1 | 1999 | 56 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1997 | 7852 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2004 | 1597 | 0.010 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2000 | 121 | 0.010 |
Why?
|
| Species Specificity | 1 | 1984 | 2419 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2832 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1992 | 6382 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 6525 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2509 | 0.010 |
Why?
|
| Adolescent | 3 | 2021 | 88305 | 0.010 |
Why?
|
| Software | 1 | 1992 | 4439 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1984 | 2382 | 0.010 |
Why?
|
| Chimera | 1 | 1999 | 453 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 2000 | 487 | 0.010 |
Why?
|
| Survival Rate | 2 | 2008 | 12710 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2001 | 773 | 0.010 |
Why?
|
| Neutropenia | 1 | 2003 | 884 | 0.010 |
Why?
|
| Blood | 1 | 2000 | 600 | 0.010 |
Why?
|
| Virus Diseases | 1 | 2003 | 719 | 0.010 |
Why?
|
| Busulfan | 1 | 1997 | 258 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1996 | 5820 | 0.010 |
Why?
|
| Carboplatin | 1 | 2000 | 794 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1791 | 0.010 |
Why?
|
| Transplantation Tolerance | 1 | 2000 | 605 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1996 | 258 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2001 | 3097 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6231 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 4466 | 0.010 |
Why?
|
| Morbidity | 1 | 2000 | 1750 | 0.010 |
Why?
|
| Living Donors | 1 | 1999 | 641 | 0.010 |
Why?
|
| RNA | 1 | 1984 | 2723 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1560 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1989 | 9319 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 3734 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 1992 | 5127 | 0.010 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1997 | 617 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36430 | 0.010 |
Why?
|
| Alleles | 1 | 1984 | 6909 | 0.010 |
Why?
|
| Atrioventricular Node | 1 | 1992 | 180 | 0.010 |
Why?
|
| Retrospective Studies | 4 | 2004 | 80575 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1999 | 2821 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2001 | 2751 | 0.010 |
Why?
|
| Mortality | 1 | 2000 | 2898 | 0.000 |
Why?
|
| Heart Diseases | 1 | 2000 | 2785 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 7999 | 0.000 |
Why?
|
| Genotype | 1 | 2000 | 12982 | 0.000 |
Why?
|
| Follow-Up Studies | 2 | 2000 | 39108 | 0.000 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2000 | 5297 | 0.000 |
Why?
|
| Equipment Design | 1 | 1993 | 3510 | 0.000 |
Why?
|
| Hemolysis | 1 | 1984 | 424 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 20092 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2003 | 41440 | 0.000 |
Why?
|
| Catheter Ablation | 1 | 1992 | 2752 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2000 | 15647 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1999 | 54405 | 0.000 |
Why?
|
| Risk Factors | 1 | 1992 | 74152 | 0.000 |
Why?
|